Their study provided evidence that FXR inhibition in the intestine by antioxidant “tempol” or by genetic ablation of FXR is effective in suppressing diet-induced obesity and insulin resistance [51,52]. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.